These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 32387798)
21. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma. Lee JW; Nam SB; Kim SJ Oncology; 2019; 97(5):286-293. PubMed ID: 31437839 [TBL] [Abstract][Full Text] [Related]
22. Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of preoperative Hu J; Zhang K; Yan Y; Zang Y; Wang Y; Xue F Arch Gynecol Obstet; 2019 Sep; 300(3):519-529. PubMed ID: 31165242 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of Kim SJ; Lee SW; Pak K; Kim IJ; Kim K Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis. Son GM; Kim SJ Abdom Radiol (NY); 2019 Feb; 44(2):456-463. PubMed ID: 30132094 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
28. Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma. Jung JH; Kim CY; Son SH; Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC PLoS One; 2015; 10(12):e0144152. PubMed ID: 26636824 [TBL] [Abstract][Full Text] [Related]
29. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X; Guo Y; Qian X Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109 [TBL] [Abstract][Full Text] [Related]
30. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer. Seol HY; Kim YS; Kim SJ Oncology; 2021; 99(2):96-104. PubMed ID: 32980838 [TBL] [Abstract][Full Text] [Related]
32. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma. Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195 [TBL] [Abstract][Full Text] [Related]
33. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk]. Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765 [No Abstract] [Full Text] [Related]
34. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis. Kim SJ; Lee JS World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873 [TBL] [Abstract][Full Text] [Related]
35. [ Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
40. A systematic review and meta-analysis of Kim SJ; Lee SW; Jeong SY; Pak K; Kim K J Vasc Surg; 2019 Jul; 70(1):307-313. PubMed ID: 30922755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]